World Conference on Lung Cancer Sunday Press Conference: Introducing New Awards and Global Guidelines
(Thomson Reuters ONE) -
YOKOHAMA, Japan, Oct. 15, 2017 (GLOBE NEWSWIRE) -- The first press briefing at
the International Association for the Study of Lung Cancer (IASLC) 18(th) World
Conference on Lung Cancer (WCLC) highlighted new awards and innovations that
encourage and support the treatment of lung cancer and other thoracic
malignancies; these include the recognition of outstanding care teams,
introduction of new guidelines for nurses and fostering the next generation of
researchers.
The press conference began with a welcome message from Conference Co-Presidents
Dr. Hisao Asamura and Dr. Keunchil Park, who have worked tirelessly to make this
year's conference in Yokohama a major success.
The first Cancer Care Team Award recognizes exceptional patient care
The IASLC Foundation is awarding its first-ever Cancer Care Team Award to
multidisciplinary cancer care teams across the globe who go above and beyond to
provide the highest-quality patient care. The award was proposed by Dr. Matthew
Holman and his wife, Marilyn, a lung cancer survivor. Jill Feldman, a lung
cancer survivor and advocate from the United States, introduced the award by
telling her story and sharing why this award is particularly meaningful to her.
"My team at Rush University has always been patient-centered and is so deserving
of this award, along with the other awardees today," said Jill Feldman. "Amazing
things are possible when teams across disciplines work together to put the
patient first. I am grateful to the IASLC Foundation for introducing an award
that encourages this kind of extraordinary teamwork."
Teams at the following institutions were recognized with the award:
* Guangdong Lung Cancer Institute (China)
* Neotorax - Oncologia D'or (Brazil)
* Instytut Gruzlicy i Chorób Pluc w Warszawie (Poland); Klinika Chorób
Wewnetrznych, Pneumonologii i Alergologii, Samodzielny Publiczny szpital
Kliniczny w Warszawie (Poland); Centrum Onkologii - Instytut im. Marii
Sklodowskiej-Curie w Warszawie (Poland)
* Johns Hopkins Hospital - Sidney Kimmel Cancer Center (USA)
* Rush University Medical Center (USA)
New guidelines for nurses provide best practices for immunotherapy treatment
At last year's WCLC in Vienna, the IASLC Nursing and Allied Health Committee
identified the need for educational support for those caring for lung cancer
patients receiving immunotherapy. During today's press conference, Kim Rohan of
the United States and Anne Fraser of New Zealand unveiled the resulting
guidelines for immunotherapy. The guidelines are an invaluable resource to
nurses and cover the life-threatening adverse effects patients may experience
during immunotherapy treatment including gastrointestinal, dermatologic,
endocrine, ocular, hepatic, neurological and pulmonary toxicities.
"These guidelines are unique in that they are the result of international
collaboration," said Anne Fraser. "As immunotherapy treatment continues to be
utilized more frequently, the guidelines will be essential to helping nurses
understand and mitigate the potential side effects."
IASLC Mentorship Award participants speak to the value of mentorship
The IASLC International Mentorship Program is a professional development and
education program for early-career thoracic malignancy-focused physicians and
researchers from economically developing countries. Thirteen mentees were
selected for the 2017 program, representing specialties from medical oncology to
pulmonology and hailing from Argentina, China, India, Indonesia, Malaysia,
Pakistan, Saudi Arabia, Serbia and Thailand. Some of the world's leading figures
in lung cancer will provide mentorship and guidance during the WCLC, as well as
host the mentees at their home institutions for a week.
A number of mentors shared their experiences with the program and underscored
the value of mentorship, including Fiona Blackhall of the United Kingdom, Ross
Camidge of the United States, Nir Peled of Israel and Mary O'Brien of the United
Kingdom.
For Prof. Blackhall, the benefits of mentorship include the ability to inspire
the next generation of oncologists and cancer researchers, serve as a female
role model in medicine and highlight areas of unmet need in lung cancer
research. Prof. Peled found that there were mutual benefits of working with his
mentee, as he has been able to enlarge his team network. Dr. Camidge, who is
based in Denver, discussed his long-distance collaboration with his mentee,
Harry Ren of China. They jointly diagnosed a patient who then traveled to Denver
for a clinical trial, demonstrating the value of global collaboration.
Mary O'Brien also spoke to why mentorship is so critical for young professionals
in the field. "Medicine is a profession traditionally taught as an
apprenticeship, learning from and watching senior doctors. Medicine has changed
and much is not taught through books and other sources of information. We need
to remember the power of human contact. A strong mentorship scheme will bring
the best out of young doctors, talents that are both obvious and hidden," said
Dr. O'Brien.
Livestreams of the daily press conferences are available here.
About the WCLC
The World Conference on Lung Cancer (WCLC) is the world's largest meeting
dedicated to lung cancer and other thoracic malignancies, attracting over 6,000
researchers, physicians and specialists from more than 100 countries. The goal
is to disseminate the latest scientific achievements; increase awareness,
collaboration and understanding of lung cancer; and to help participants
implement the latest developments across the globe. Organized under the theme of
"Synergy to Conquer Lung Cancer," the conference will cover a wide range of
disciplines and unveil several research studies and clinical trial results. For
more information, visit wclc2017.iaslc.org.
About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only
global organization dedicated to the study of lung cancer and other thoracic
malignancies. Founded in 1974, the association's membership includes more than
6,500 lung cancer specialists across all disciplines in over 100 countries,
forming a global network working together to conquer lung and thoracic cancers
worldwide. The association also publishes the Journal of Thoracic Oncology, the
primary educational and informational publication for topics relevant to the
prevention, detection, diagnosis and treatment of all thoracic malignancies.
Visit www.iaslc.org for more information.
Contacts:
Hillary Wasserman
Senior Associate
HWasserman(at)GroupGordon.com
+1 732-778-1896
Becky Bunn, MSc
Public Relations Manager
Becky.Bunn(at)IASLC.org
+1 720-254-9509
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: IASLC via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 15.10.2017 - 09:47 Uhr
Sprache: Deutsch
News-ID 563680
Anzahl Zeichen: 7804
contact information:
Town:
Aurora, Colorado
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 382 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"World Conference on Lung Cancer Sunday Press Conference: Introducing New Awards and Global Guidelines"
steht unter der journalistisch-redaktionellen Verantwortung von
IASLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
